Women's cancer drugs
These companies develop or sell drugs that treat breast, ovarian, endometrial and cervical cancers.
+6.2%
over 1 year · S&P 500 +11.6%
Key indicators
Health
50 / 100
Fragile
Solid
Price
P/E 26
Cheap
Expensive
Up over 1 year
6 of 12
Volatility
70%
Calm
Choppy
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 13 companies
CORT
−7.0%
RLAY
+193.2%
CELC
−24.4%
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
C
Corcept Therapeutics
CORT
42.5%
−7.0%
R
Relay Therapeutics
RLAY
21.0%
+193.2%
C
Celcuity
CELC
17.3%
−24.4%
V
Verastem
VSTM
5.7%
−3.9%
R
Rigel Pharmaceuticals
RIGL
4.5%
+11.3%
O
Olema Pharmaceuticals
OLMA
3.7%
−6.2%
P
Puma Biotechnology
PBYI
2.1%
+55.7%
F
Faeth Therapeutics
FTH
1.8%
−0.7%
Z
Zentalis Pharmaceuticals
ZNTL
0.9%
+26.9%
A
Acrivon Therapeutics
ACRV
0.4%
−36.4%
A
AstraZeneca
AZN
G
Genmab
GMAB
+68.6%
Z
Zai Lab
ZLAB
+12.4%